Table 1.
Patients’ clinical characteristics
| Characteristic | AMD-ME | BRVO-ME | DME | CON |
|---|---|---|---|---|
| Eyes (cases) | 20 (20) | 20 (20) | 20 (20) | 20 (20) |
| Male/female | 11/9 | 11/9 | 8/12 | 10/10 |
| Age (years) | 63.7 | 61.7 | 58.2 | 60.3 |
| Hypertension | 7 (35%) | 8 (40%) | 7 (35%) | 9 (45%) |
| Diabetes | 0 (0%) | 0 (0%) | 20 (100%) | 0 (0%) |
| Cataract | 80% | 65% | 75% | 100% |
| Anti-VEGF (within 3 months) | 0% | 0% | 0% | 0% |
| Eye surgery (within 3 months) | 0% | 0% | 0% | 0% |
| Vitreous hemorrhage | 0% | 0% | 0% | 0% |
AMD = age-related macular degeneration; ME = macular edema; BRVO = branch retinal vein occlusion; DME = diabetic macular edema; CON = control group; VEGF = vascular endothelial derived growth factor